Global Medical 3D Printing Biomaterials 麻豆原创 Research Report 2025

Publication ID:

PB503250782

Publication Date:

March 6, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Medical 3D Printing Biomaterials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The majority of biomaterials used in current medical 3D printing technology, such as metals, ceramics, hard polymers, and composites, are stiff, and thus widely used for orthodontic applications. Soft polymers, including hydrogels, are widely used in bioprinting cells for tissue/organ fabrication.
North American market for Medical 3D Printing Biomaterials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Medical 3D Printing Biomaterials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Medical 3D Printing Biomaterials in Orthopaedic is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Medical 3D Printing Biomaterials include Stryker, Stratasys, 3D Systems, Medtronic, Johnson & Johnson, Zimmer Biomet, Lima Corporation, EOS GmbH, Conformis, Smith & Nephew, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Medical 3D Printing Biomaterials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical 3D Printing Biomaterials.
The Medical 3D Printing Biomaterials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medical 3D Printing Biomaterials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical 3D Printing Biomaterials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Stryker
Stratasys
3D Systems
Medtronic
Johnson & Johnson
Zimmer Biomet
Lima Corporation
EOS GmbH
Conformis
Smith & Nephew
Adler Ortho
Exactech
AK Medical Holding
Envision Tec
Carima
Mitsubishi Chemical
Esun
Segment by Type
Metal
Ceramics
Hard Polymers
Other
Segment by Application
Orthopaedic
Stomatology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical 3D Printing Biomaterials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Medical 3D Printing Biomaterials 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Metal
1.2.3 Ceramics
1.2.4 Hard Polymers
1.2.5 Other
1.3 麻豆原创 by Application
1.3.1 Global Medical 3D Printing Biomaterials 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Orthopaedic
1.3.3 Stomatology
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medical 3D Printing Biomaterials 麻豆原创 Perspective (2020-2031)
2.2 Global Medical 3D Printing Biomaterials Growth Trends by Region
2.2.1 Global Medical 3D Printing Biomaterials 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Medical 3D Printing Biomaterials Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Medical 3D Printing Biomaterials Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Medical 3D Printing Biomaterials 麻豆原创 Dynamics
2.3.1 Medical 3D Printing Biomaterials Industry Trends
2.3.2 Medical 3D Printing Biomaterials 麻豆原创 Drivers
2.3.3 Medical 3D Printing Biomaterials 麻豆原创 Challenges
2.3.4 Medical 3D Printing Biomaterials 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical 3D Printing Biomaterials Players by Revenue
3.1.1 Global Top Medical 3D Printing Biomaterials Players by Revenue (2020-2025)
3.1.2 Global Medical 3D Printing Biomaterials Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Medical 3D Printing Biomaterials 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Medical 3D Printing Biomaterials Revenue
3.4 Global Medical 3D Printing Biomaterials 麻豆原创 Concentration Ratio
3.4.1 Global Medical 3D Printing Biomaterials 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical 3D Printing Biomaterials Revenue in 2024
3.5 Global Key Players of Medical 3D Printing Biomaterials Head office and Area Served
3.6 Global Key Players of Medical 3D Printing Biomaterials, Product and Application
3.7 Global Key Players of Medical 3D Printing Biomaterials, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Medical 3D Printing Biomaterials Breakdown Data by Type
4.1 Global Medical 3D Printing Biomaterials Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Medical 3D Printing Biomaterials Forecasted 麻豆原创 Size by Type (2026-2031)
5 Medical 3D Printing Biomaterials Breakdown Data by Application
5.1 Global Medical 3D Printing Biomaterials Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Medical 3D Printing Biomaterials Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Medical 3D Printing Biomaterials 麻豆原创 Size (2020-2031)
6.2 North America Medical 3D Printing Biomaterials 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Medical 3D Printing Biomaterials 麻豆原创 Size by Country (2020-2025)
6.4 North America Medical 3D Printing Biomaterials 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medical 3D Printing Biomaterials 麻豆原创 Size (2020-2031)
7.2 Europe Medical 3D Printing Biomaterials 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Medical 3D Printing Biomaterials 麻豆原创 Size by Country (2020-2025)
7.4 Europe Medical 3D Printing Biomaterials 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medical 3D Printing Biomaterials 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Medical 3D Printing Biomaterials 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Medical 3D Printing Biomaterials 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Medical 3D Printing Biomaterials 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medical 3D Printing Biomaterials 麻豆原创 Size (2020-2031)
9.2 Latin America Medical 3D Printing Biomaterials 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Medical 3D Printing Biomaterials 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Medical 3D Printing Biomaterials 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical 3D Printing Biomaterials 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Medical 3D Printing Biomaterials 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Medical 3D Printing Biomaterials 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Medical 3D Printing Biomaterials 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Stryker
11.1.1 Stryker Company Details
11.1.2 Stryker Business Overview
11.1.3 Stryker Medical 3D Printing Biomaterials Introduction
11.1.4 Stryker Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.1.5 Stryker Recent Development
11.2 Stratasys
11.2.1 Stratasys Company Details
11.2.2 Stratasys Business Overview
11.2.3 Stratasys Medical 3D Printing Biomaterials Introduction
11.2.4 Stratasys Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.2.5 Stratasys Recent Development
11.3 3D Systems
11.3.1 3D Systems Company Details
11.3.2 3D Systems Business Overview
11.3.3 3D Systems Medical 3D Printing Biomaterials Introduction
11.3.4 3D Systems Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.3.5 3D Systems Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Details
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Medical 3D Printing Biomaterials Introduction
11.4.4 Medtronic Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.4.5 Medtronic Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Medical 3D Printing Biomaterials Introduction
11.5.4 Johnson & Johnson Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 Zimmer Biomet
11.6.1 Zimmer Biomet Company Details
11.6.2 Zimmer Biomet Business Overview
11.6.3 Zimmer Biomet Medical 3D Printing Biomaterials Introduction
11.6.4 Zimmer Biomet Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.6.5 Zimmer Biomet Recent Development
11.7 Lima Corporation
11.7.1 Lima Corporation Company Details
11.7.2 Lima Corporation Business Overview
11.7.3 Lima Corporation Medical 3D Printing Biomaterials Introduction
11.7.4 Lima Corporation Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.7.5 Lima Corporation Recent Development
11.8 EOS GmbH
11.8.1 EOS GmbH Company Details
11.8.2 EOS GmbH Business Overview
11.8.3 EOS GmbH Medical 3D Printing Biomaterials Introduction
11.8.4 EOS GmbH Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.8.5 EOS GmbH Recent Development
11.9 Conformis
11.9.1 Conformis Company Details
11.9.2 Conformis Business Overview
11.9.3 Conformis Medical 3D Printing Biomaterials Introduction
11.9.4 Conformis Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.9.5 Conformis Recent Development
11.10 Smith & Nephew
11.10.1 Smith & Nephew Company Details
11.10.2 Smith & Nephew Business Overview
11.10.3 Smith & Nephew Medical 3D Printing Biomaterials Introduction
11.10.4 Smith & Nephew Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.10.5 Smith & Nephew Recent Development
11.11 Adler Ortho
11.11.1 Adler Ortho Company Details
11.11.2 Adler Ortho Business Overview
11.11.3 Adler Ortho Medical 3D Printing Biomaterials Introduction
11.11.4 Adler Ortho Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.11.5 Adler Ortho Recent Development
11.12 Exactech
11.12.1 Exactech Company Details
11.12.2 Exactech Business Overview
11.12.3 Exactech Medical 3D Printing Biomaterials Introduction
11.12.4 Exactech Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.12.5 Exactech Recent Development
11.13 AK Medical Holding
11.13.1 AK Medical Holding Company Details
11.13.2 AK Medical Holding Business Overview
11.13.3 AK Medical Holding Medical 3D Printing Biomaterials Introduction
11.13.4 AK Medical Holding Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.13.5 AK Medical Holding Recent Development
11.14 Envision Tec
11.14.1 Envision Tec Company Details
11.14.2 Envision Tec Business Overview
11.14.3 Envision Tec Medical 3D Printing Biomaterials Introduction
11.14.4 Envision Tec Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.14.5 Envision Tec Recent Development
11.15 Carima
11.15.1 Carima Company Details
11.15.2 Carima Business Overview
11.15.3 Carima Medical 3D Printing Biomaterials Introduction
11.15.4 Carima Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.15.5 Carima Recent Development
11.16 Mitsubishi Chemical
11.16.1 Mitsubishi Chemical Company Details
11.16.2 Mitsubishi Chemical Business Overview
11.16.3 Mitsubishi Chemical Medical 3D Printing Biomaterials Introduction
11.16.4 Mitsubishi Chemical Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.16.5 Mitsubishi Chemical Recent Development
11.17 Esun
11.17.1 Esun Company Details
11.17.2 Esun Business Overview
11.17.3 Esun Medical 3D Printing Biomaterials Introduction
11.17.4 Esun Revenue in Medical 3D Printing Biomaterials Business (2020-2025)
11.17.5 Esun Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Stryker
Stratasys
3D Systems
Medtronic
Johnson & Johnson
Zimmer Biomet
Lima Corporation
EOS GmbH
Conformis
Smith & Nephew
Adler Ortho
Exactech
AK Medical Holding
Envision Tec
Carima
Mitsubishi Chemical
Esun

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.